{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:00:44Z","timestamp":1791342044639,"version":"4.3.1"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi221005-4\"><jats:title>Importance<\/jats:title><jats:p>Emerging evidence implicates a role for neuroinflammation in Alzheimer disease (AD) pathogenesis, predominantly involving the innate immune system. Blood leukocyte counts are easily accessible markers of immune function; however, their association with the risk of AD is unknown.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221005-5\"><jats:title>Objective<\/jats:title><jats:p>To investigate the observational and genetic associations between types of blood leukocytes and risk of AD.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221005-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>In a cohort study comprising observational and genetic analyses, the Copenhagen General Population Study prospective cohort (n\u2009=\u2009101\u202f582) was used for the observational analyses. For the genetic studies, nonlinearity was first evaluated for the association between leukocyte cell counts and AD risk using individual-level data from the UK Biobank (n\u2009=\u2009365\u202f913). Subsequently, a 2-sample mendelian randomization framework was applied using genetic instruments for blood leukocyte counts (n\u2009=\u2009563 085); for AD, the European Alzheimer &amp;amp;amp; Dementia Biobank was used, including 85\u202f934 individuals with AD and 401\u202f577 controls and the International Genomics of Alzheimer\u2019s Project, including 21\u202f982 individuals with AD and 41\u202f944 controls.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221005-7\"><jats:title>Exposures<\/jats:title><jats:p>Observational and genetically determined types of blood leukocyte counts.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221005-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Hazard ratios (HRs) and 95% CIs for AD of cell count percentile groups in observational studies and odds ratios (ORs) and 95% CIs for AD per 1 SD genetically determined cell counts.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221005-9\"><jats:title>Results<\/jats:title><jats:p>This cohort study included 101\u202f582 participants (55 891 [55.0%] women) with a median age of 58 years (IQR, 48-67 years); of these, 1588 individuals developed AD. Multivariable-adjusted HRs for participants in the less than 5th vs the 25th to 75th (reference) percentile group were 1.24 (95% CI, 0.99-1.54) for blood monocytes and 1.25 for blood eosinophils (95% CI, 1.05-1.50). For participants in the greater than 95th vs the 25th to 75th percentile group, the HR was 1.30 (95% CI, 1.06-1.61) for blood neutrophils. Genetically, no evidence favored possible nonlinear associations. The ORs for AD per 1-SD decrease in genetically determined blood monocytes were 1.04 (95% CI, 1.00-1.10) in the European Alzheimer &amp;amp;amp; Dementia Biobank consortium and 1.09 (95% CI, 1.01-1.17) in the International Genomics of Alzheimer\u2019s Project consortium. Using mendelian randomization, sensitivity analyses and multivariable analysis showed similar results.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221005-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>The findings of this study suggest that low blood monocyte counts are associated with increased AD risk. These findings highlight a potential role of the innate immune system in AD pathogenesis.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.35648","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T15:23:08Z","timestamp":1665415388000},"page":"e2235648","source":"Crossref","is-referenced-by-count":35,"title":["Blood Leukocyte Counts in Alzheimer Disease"],"prefix":"10.1001","volume":"5","author":[{"given":"Jiao","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2013Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands"},{"name":"Section of Gerontology and Geriatrics, Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Qvist","family":"Thomassen","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2013Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge G.","family":"Nordestgaard","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2013Herlev and Gentofte, Herlev, Denmark"},{"name":"The Copenhagen General Population Study, Copenhagen University Hospital\u2013Herlev and Gentofte, Herlev, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tybj\u00e6rg-Hansen","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2013Rigshospitalet, Copenhagen, Denmark"},{"name":"The Copenhagen General Population Study, Copenhagen University Hospital\u2013Herlev and Gentofte, Herlev, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Frikke-Schmidt","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2013Rigshospitalet, Copenhagen, Denmark"},{"name":"The Copenhagen General Population Study, Copenhagen University Hospital\u2013Herlev and Gentofte, Herlev, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"issue":"10248","key":"zoi221005r1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"zoi221005r2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease.","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"zoi221005r3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease.","volume":"368","author":"Jonsson","year":"2013","journal-title":"N Engl J Med"},{"issue":"16","key":"zoi221005r4","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1056\/NEJMc1306509","article-title":"TREM2 and neurodegenerative disease.","volume":"369","author":"Reitz","year":"2013","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi221005r5","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nn.3435","article-title":"CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology.","volume":"16","author":"Bradshaw","year":"2013","journal-title":"Nat Neurosci"},{"issue":"10","key":"zoi221005r6","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease.","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat Genet"},{"issue":"12","key":"zoi221005r7","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease.","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat Genet"},{"issue":"4","key":"zoi221005r8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias.","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat Genet"},{"issue":"3","key":"zoi221005r9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.celrep.2013.10.010","article-title":"Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta.","volume":"5","author":"Michaud","year":"2013","journal-title":"Cell Rep"},{"issue":"2","key":"zoi221005r10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3233\/JAD-2009-0964","article-title":"Peripheral amyloid-beta levels regulate amyloid-beta clearance from the central nervous system.","volume":"16","author":"Marques","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"zoi221005r11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fimmu.2020.00049","article-title":"Activated bone marrow-derived macrophages eradicate Alzheimer\u2019s-related A\u00df42 oligomers and protect synapses.","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"zoi221005r12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41593-018-0329-4","article-title":"Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer\u2019s disease mouse models.","volume":"22","author":"Cruz Hern\u00e1ndez","year":"2019","journal-title":"Nat Neurosci"},{"issue":"8","key":"zoi221005r13","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.3913","article-title":"Neutrophils promote Alzheimer\u2019s disease\u2013like pathology and cognitive decline via LFA-1 integrin.","volume":"21","author":"Zenaro","year":"2015","journal-title":"Nat Med"},{"issue":"8","key":"zoi221005r14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/syn.21651","article-title":"Peripheral markers of Alzheimer\u2019s disease: surveillance of white blood cells.","volume":"67","author":"Shad","year":"2013","journal-title":"Synapse"},{"issue":"21","key":"zoi221005r15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006843","article-title":"Altered peripheral profile of blood cells in Alzheimer disease: a hospital-based case-control study.","volume":"96","author":"Chen","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"zoi221005r16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3389\/fnagi.2019.00332","article-title":"Predictive value of routine peripheral blood biomarkers in Alzheimer\u2019s disease.","volume":"11","author":"Dong","year":"2019","journal-title":"Front Aging Neurosci"},{"issue":"20","key":"zoi221005r17","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"zoi221005r18","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.cell.2020.08.008","article-title":"The polygenic and monogenic basis of blood traits and diseases.","volume":"182","author":"Vuckovic","year":"2020","journal-title":"Cell"},{"issue":"3","key":"zoi221005r19","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u00df, tau, immunity and lipid processing.","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat Genet"},{"issue":"4","key":"zoi221005r20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.2016.40.issue-4","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"2","key":"zoi221005r21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"5","key":"zoi221005r22","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"issue":"4","key":"zoi221005r24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/aje\/kwu283","article-title":"Multivariable mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects.","volume":"181","author":"Burgess","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"1","key":"zoi221005r25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41398-020-01113-9","article-title":"Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer\u2019s disease.","volume":"10","author":"Chen","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"1","key":"zoi221005r26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13024-018-0293-1","article-title":"Functional alterations of myeloid cells during the course of Alzheimer\u2019s disease.","volume":"13","author":"Thome","year":"2018","journal-title":"Mol Neurodegener"},{"issue":"3","key":"zoi221005r27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00401-016-1596-3","article-title":"Innate phagocytosis by peripheral blood monocytes is altered in Alzheimer\u2019s disease.","volume":"132","author":"Gu","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"1","key":"zoi221005r28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41398-021-01400-z","article-title":"Circulating biomarkers of immunity and inflammation, risk of Alzheimer\u2019s disease, and hippocampal volume: a mendelian randomization study.","volume":"11","author":"Fani","year":"2021","journal-title":"Transl Psychiatry"},{"issue":"4","key":"zoi221005r29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","article-title":"Bone marrow\u2013derived microglia play a critical role in restricting senile plaque formation in Alzheimer\u2019s disease.","volume":"49","author":"Simard","year":"2006","journal-title":"Neuron"},{"issue":"5","key":"zoi221005r30","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/jmcb\/mjt028","article-title":"A deficiency in CCR2+ monocytes: the hidden side of Alzheimer\u2019s disease.","volume":"5","author":"Naert","year":"2013","journal-title":"J Mol Cell Biol"},{"issue":"4","key":"zoi221005r31","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nm1555","article-title":"Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease.","volume":"13","author":"El Khoury","year":"2007","journal-title":"Nat Med"},{"issue":"1","key":"zoi221005r32","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41598-018-19807-y","article-title":"Plasma MCP-1 and Cognitive Decline In Patients with Alzheimer\u2019s disease and mild cognitive impairment: a two-year follow-up study.","volume":"8","author":"Lee","year":"2018","journal-title":"Sci Rep"},{"key":"zoi221005r33","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12568","article-title":"C-reactive protein levels and risk of dementia\u2014observational and genetic studies of 111,242 individuals from the general population.","author":"Hegazy","journal-title":"Alzheimers Dement"},{"issue":"5","key":"zoi221005r34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1136\/jmedgenet-2018-105421","article-title":"Biallelic mutations in EXOC3L2 cause a novel syndrome that affects the brain, kidney and blood.","volume":"56","author":"Shalata","year":"2019","journal-title":"J Med Genet"},{"issue":"9","key":"zoi221005r35","doi-asserted-by":"publisher","first-page":"E2403","DOI":"10.1002\/humu.22619","article-title":"Online registry for mutations in hereditary amyloidosis including nomenclature recommendations.","volume":"35","author":"Rowczenio","year":"2014","journal-title":"Hum Mutat"},{"issue":"3","key":"zoi221005r37","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000107084","article-title":"Validity of dementia diagnoses in the Danish hospital registers.","volume":"24","author":"Phung","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"zoi221005r38","doi-asserted-by":"publisher","first-page":"j5375","DOI":"10.1136\/bmj.j5375","article-title":"Modifiable pathways in Alzheimer\u2019s disease: mendelian randomisation analysis.","volume":"359","author":"Larsson","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"zoi221005r39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ana.v89.1","article-title":"Causal associations between modifiable risk factors and the Alzheimer\u2019s phenome.","volume":"89","author":"Andrews","year":"2021","journal-title":"Ann Neurol"},{"key":"zoi221005r23","unstructured":"GitHub Inc. kn3in\/mRnd. Accessed December 17, 2021. https:\/\/github.com\/kn3in\/mRnd"},{"key":"zoi221005r36","unstructured":"Sundhedsstyrelsen. National retningslinje for udredning og behandling af demens. 2013. Accessed August 29, 2022. https:\/\/www.sst.dk\/da\/udgivelser\/2013\/-\/media\/Udgivelser\/2013\/Publ2013\/NKR-for-udredning-og-behandling--af-demens.ashx#:~:text=delsen%20af%20retningslinjen.-,Den%20nationale%20kliniske%20retningslinje%20for%20udredning%20og%20behandling%20af%20demens,l%C3%A6ses%20af%20beslutningstagere%20og%20planl%C3%A6ggere"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2797072\/luo_2022_oi_221005_1664382870.41124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T15:23:15Z","timestamp":1665415395000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2797072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.35648","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]}}}